Connect your AI

MAZE MAZE Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Septerna, Inc.SEPN

$755K-21.8%

Nurix Therapeutics, Inc.NRIX

$1.98M-44.4%

MapLight Therapeutics, Inc. MPLT

$814K+217%

Relay Therapeutics, Inc.RLAY

$782K-51.0%

Adaptive BiotechnologiesADPT

$136K-85.8%

Cogent Biosciences, Inc.COGT

$1.18M+23.6%

Other financials

Income statement

Revenue$20.0M—

Operating income-$26.6M+25.0%

Net income-$24.2M+26.2%

EPS (diluted)-$0.45+60.9%

Balance sheet

Cash & equivalents$198.8M-32.5%

Total debt$61.2M+137%

Total equity$341.7M+17.0%

Total assets$419.7M+26.1%

Cash flow

Operating cash flow-$39.1M-32.5%

CapEx$93.0K-68.9%

Free cash flow-$39.2M-31.5%

Valuation

Market cap$1.48B—

Enterprise value$1.34B—

P/S7.9×—

Profitability

Operating margin-71.5%—

Net margin-65.4%—

FCF margin-65.1%—

Returns & leverage

Return on equity-38.7%—

Debt / equity0.2×+0.1×

Current ratio17.9×+1.8×

Where this comes from

Reported directly by MAZE in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is MAZE's accretion (amortization) of discounts and premiums, investments?: MAZE (MAZE) reported accretion (amortization) of discounts and premiums, investments of $2K in Q1 2026.
What does accretion (amortization) of discounts and premiums, investments mean?: Reflects the periodic adjustment to the carrying value of investment securities to account for the difference between the purchase price and the face value. This adjustment aligns the investment's book value with its expected maturity value over time.